Association of organ dysfunction trajectories and major adverse cardiovascular events using clinical obesity in UK Biobank - Takeaways - MDSpire

Association of organ dysfunction trajectories and major adverse cardiovascular events using clinical obesity in UK Biobank

  • By

  • Yohwan Lim

  • Su Kyoung Lee

  • May 14, 2026

  • 0 min

Share

  • 1

    Obesity is a significant modifiable risk factor for cardiovascular disease, necessitating improved risk stratification methods.

  • 2

    The study analyzed 457,675 UK Biobank participants to evaluate the association between organ dysfunction trajectories and major adverse cardiovascular events.

  • 3

    Clinical obesity, defined by organ dysfunction, showed a higher risk of major adverse cardiovascular events compared to BMI-based categories.

  • 4

    Persistent organ dysfunction was linked to the highest risk of major adverse cardiovascular events, with a 10-year cumulative incidence of ~24% in clinical obesity.

  • 5

    Incorporating clinical obesity definitions with longitudinal assessments of organ dysfunction may enhance cardiovascular risk stratification.

Original Source(s)

Association of organ dysfunction trajectories and major adverse cardiovascular events using clinical obesity in UK Biobank

  • by Yohwan Lim, Su Kyoung Lee

  • May 14, 2026

Related Content

Dietary Fats Linked to Lower Odds of Hearing Loss

NHANES analysis shows inverse dose-response associations for omega-3 and omega-6 intake, with no link for fatty acid ratio

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Pregestational Cardiometabolic Biomarkers and Future Hypertensive Disorders of Pregnancy